Literature DB >> 12878041

Modulation of macrophage apoptosis by antimycobacterial therapy: physiological role of apoptosis in the control of Mycobacterium tuberculosis.

Diana Gil1, Luis F Garcia, Mauricio Rojas.   

Abstract

Apoptosis is a form of cell death that avoids inflammatory responses. We had previously reported that Mycobacterium tuberculosis (Mtb) and Purified Protein Derivative (PPD) induce apoptosis in murine macrophages. The production of TNFalpha and IL-10 in response to Mtb infection modulates apoptosis by controlling nitric oxide production and caspase activation. Furthermore, Mtb triggers calcium influx responsible for mitochondrial alterations, an early pathway of apoptosis, independently of TNFalpha and IL-10. In tuberculosis patients apoptotic macrophages are found in granulomas and bronchoalveolar lavages, suggesting that apoptosis may participate in the control of Mtb. To further explore the role of macrophage apoptosis in tuberculosis, we studied the capacity of standard antimycobacterial drugs to modulate different events associated with the induction of apoptosis. The B10R murine macrophage line was infected or not with Mtb (5:1 bacteria to macrophage ratio) or exposed to PPD (10 microg/ml), in the presence or absence of varying concentrations (1-20 microg/ml) of anti mycobacterial drugs (isoniazid, rifampin, thiacetazone, streptomycin, and ethambutol). Inhibition of the intracellular growth of M. tuberculosis by all drugs studied/correlated with inhibition of permeability transition (PT) alterations; TNFalpha, IL-10, and nitric oxide production, and caspase-1 activation. However, these drugs did not affect PPD-induced apoptosis or its associated events, suggesting that the ability of antimycobacterial drugs to block macrophage apoptosis could be explained by their effects on the metabolic activities of Mtb. All drugs, except isoniazid, at higher concentrations, induced PT alterations in noninfected macrophages in a way that appears to be dependent of calcium, since a calcium chelator prevented it. The results presented herein suggest that the pharmacological manipulation of pathways associated with macrophage apoptosis may affect the intracellular growth of Mtb.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878041     DOI: 10.1016/s0041-008x(03)00162-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Rifampin augments cytokine-induced nitric oxide production in human alveolar epithelial cells.

Authors:  Yael Yuhas; Eva Berent; Hila Ovadiah; Inbar Azoulay; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis.

Authors:  Soujanya D Yelamanchi; Archita Mishra; Santosh Kumar Behra; Gayathree Karthikkeyan; Thottethodi Subrahmanya Keshava Prasad; Avadhesha Surolia
Journal:  Metabolites       Date:  2022-05-29

3.  Inhibition of DNA primase and induction of apoptosis by 3,3'-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells.

Authors:  Zhi-Ming Li; Zong-Chao Liu; Zhong-Zhen Guan; Xiao-Feng Zhu; Jun-Min Zhou; Bing-Fen Xie; Gong-Kan Feng; Zhen-Yu Zhu; Wen-Qi Jiang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

4.  Rifampin inhibits prostaglandin E2 production and arachidonic acid release in human alveolar epithelial cells.

Authors:  Yael Yuhas; Inbar Azoulay-Alfaguter; Eva Berent; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

5.  Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.

Authors:  Claudia Manca; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Gilla Kaplan; Selvakumar Subbian
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.